Tag Archives: Boehringer Ingelheim and Eli Lilly and Company

Eli Lilly and Company and Boehringer Ingelheim announce new drug application filing in the U.S. for new insulin glargine product

– New Drug Application follows submission of Marketing Authorisation Application to the European Medicines Agency

INDIANAPOLIS and INGELHEIM, Germany, Dec. 20, 2013 / PRNewswire – Eli Lilly and Company and Boehringer Ingelheim today announced that …